Atropine-effect during propofol/remifentanil inductio

• Conditions: ophthalmic surgery; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

• Registration Number: EUCTR2012-002834-36-NL
• Lead Sponsor: MCG

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-06-29
• Last Update Posted: 2 October 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

All patients scheduled to undergo elective ophthalmic surgery under general anesthesia.
Patients must be 18 years or older.
No selection will be made regarding gender, age, ASA-classification, co-morbidity or ethnic background.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

- Patient’s refusal
- Patient’s age < 18 years
- Patients in which atropine is contra-indicated, such as severe aortic valve stenosis, hypertrophic cardiomyopathy or coronary artery disease

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified